These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36998140)
1. The Potential of Lipid Droplet-associated Genes as Diagnostic and Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma. Bai YT; Wang X; He MJ; Xie JR; Chen XJ; Zhou G Comb Chem High Throughput Screen; 2024; 27(1):136-147. PubMed ID: 36998140 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma. He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672 [TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis. Bai R; Rebelo A; Kleeff J; Sunami Y Lipids Health Dis; 2021 Jun; 20(1):58. PubMed ID: 34078402 [TBL] [Abstract][Full Text] [Related]
4. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Chen L; He X; Yi S; Liu G; Liu Y; Ling Y Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816 [TBL] [Abstract][Full Text] [Related]
5. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
6. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Hu Y; Guo G; Li J; Chen J; Tan P Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689 [TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
8. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648 [TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation. Zhong Q; Zhou L; Zhu D J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801 [TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma. Yang J; Jiang Q; Liu L; Peng H; Wang Y; Li S; Tang Y; Yu J; Gan R; Liu Z Aging (Albany NY); 2020 Nov; 12(24):25778-25804. PubMed ID: 33232279 [TBL] [Abstract][Full Text] [Related]
14. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma. Zhao X; Cui L J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519 [TBL] [Abstract][Full Text] [Related]
15. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
16. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis. Ding Y; Li M; Tayier T; Chen L; Feng S Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035 [TBL] [Abstract][Full Text] [Related]
17. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival. Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma. Liu H; Ye Z; Wang X; Wu Y; Deng C J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101937. PubMed ID: 38844022 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma. Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482 [TBL] [Abstract][Full Text] [Related]
20. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. Namani A; Matiur Rahaman M; Chen M; Tang X BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]